Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

November 6, 2025 updated by: City of Hope Medical Center

Intervention to Promote Uptake of Cancer Risk Counseling for Underserved Latinas

This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.

Study Overview

Detailed Description

PRIMARY OBJECTIVES:

I. To conduct a randomized trial of a culturally-informed pre-genetic cancer risk assessment (GCRA) telephone intervention.

II. To evaluate the effect of the pre-GCRA intervention versus a time and attention control versus standard scheduling procedure alone (usual care) on levels of anxiety, perceived personal control and cancer genetics knowledge.

III. To explore patients' experiences with the pre-GCRA intervention through post-intervention telephone interviews.

SECONDARY OBJECTIVES:

I. To explore patients' perceived barriers to GCRA through no-show telephone interviews.

OUTLINE:

Patients are randomized to 1 of 3 treatment arms.

ARM I: Patients receive a culturally-informed adapted motivational interviewing telephone call.

ARM II: Patients participate in a controlled condition comprising a health habits intervention group.

ARM III: Patients receive usual care comprising a standard scheduling phone call and proceed with normal GCRA process. All patients are mailed standard new patient packets containing questionnaires on demographics and personal health history, and a family history form. All patients then undergo genetic cancer risk assessment.

Study Type

Interventional

Enrollment (Actual)

493

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Duarte, California, United States, 91010
        • City of Hope Medical Center
      • Los Angeles, California, United States, 90033
        • University of Southern California-Keck School of Medicine
      • Sylmar, California, United States, 91342
        • Olive View-UCLA Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals who have a personal history of hereditary breast or ovarian cancer; a subset of 60 women without a personal history of hereditary or ovarian cancer will be included in an exploratory subset analysis
  • Meet NCCN criteria for consideration of genetic testing for hereditary breast cancer
  • Willing to sign consent
  • Pregnant women and women of child-bearing potential are eligible for participation in this study
  • Women who report themselves to be of Latino or Hispanic ethnic background (defined as Spanish, Mexican, Central or South American, Cuban, Puerto Rican, Dominican, or other Hispanic origin)
  • Women who are under- or uninsured and come from low-income communities
  • Ability to understand English or Spanish

Exclusion Criteria:

  • Previous participation in GCRA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm I
Patients receive a culturally-informed adapted motivational interviewing telephone call.
Ancillary studies
Ancillary studies
Telephone intervention
Other Names:
  • counseling and communications studies
Telephone intervention
Other Names:
  • intervention, educational
Experimental: Arm II
Patients participate in a controlled condition comprising a health habits intervention group.
Ancillary studies
Ancillary studies
Telephone intervention
Other Names:
  • counseling and communications studies
Active Comparator: Arm III
Patients receive usual care comprising a standard scheduling phone call and proceed with normal GCRA process.
Ancillary studies
Ancillary studies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of pre-GCRA intervention versus a time and attention control versus standard scheduling procedure alone (usual) on levels of anxiety, perceived personal control and cancer genetic knowledge
Time Frame: One week after genetic cancer risk assessment (GCRA)
Tested using 3 x 3 repeated measures analysis of covariance (ANCOVA)s in which the within subjects variables are anxiety or perceived control, the between groups variable is group membership, and covariates include fatalism and other appropriate moderators.
One week after genetic cancer risk assessment (GCRA)
Experiences with the pre-GCRA intervention through post-intervention telephone interviews
Time Frame: One week after genetic cancer risk assessment (GCRA)
One week after genetic cancer risk assessment (GCRA)
Conduct a randomized controlled trial of a culturally-informed pre-GCRA telephone intervention utilizing AMI techniques
Time Frame: One week after genetic cancer risk assessment (GCRA)
Will use a multivariate ANCOVA (MANCOVA) to test for group differences among all five preparedness scores, with step-down F ratios of each individual score, using fatalism and other moderators as covariates, as appropriate.
One week after genetic cancer risk assessment (GCRA)

Secondary Outcome Measures

Outcome Measure
Time Frame
Perceived barriers to GCRA through no-show telephone interviews
Time Frame: One week after genetic cancer risk assessment (GCRA)
One week after genetic cancer risk assessment (GCRA)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bita Nehoray, City of Hope Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2010

Primary Completion (Actual)

November 10, 2016

Study Completion (Estimated)

September 25, 2026

Study Registration Dates

First Submitted

September 22, 2010

First Submitted That Met QC Criteria

October 27, 2010

First Posted (Estimated)

October 29, 2010

Study Record Updates

Last Update Posted (Estimated)

November 7, 2025

Last Update Submitted That Met QC Criteria

November 6, 2025

Last Verified

November 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on BRCA1 Syndrome

Clinical Trials on questionnaire administration

Subscribe